CD44 and mesothelioma: Using CD44, hyaluronan and HASs as putative markers for differentiating MPM from adenocarcinomas (ADCs), Törrönen et al. [83] recently found a surprisingly low CD44 positivity of stromal cells in ADCs as compared to mesotheliomas (MPMs).